Inhibition of p38 kinase activity using substituted heterocyclic ureas

Yie W. Chien, Transdermal controlled systemic medications Published in <b>1987</b> in New York NY) by Dekker. ,(1987)

J. Seyden-Penne, Reductions by the alumino- and borohydrides in organic synthesis ,(1991)

Mark W. Creswell, Andrew D. White, 2-heteroatom containing urea and thiourea ACAT inhibitors ,(1991)

Timothy Bruno Lowinger, Uday Khire, Jeffrey Johnson, Jill E. Wood, Aniko Redman, William J. Scott, Roger A. Smith, Bernd Riedl, Jacques Dumas, Robert Sibley, Holia Hatoum-Mokdad, Inhibition of p38 kinase activity using aryl and heteroaryl substituted heterocyclic ureas ,(1998)

Nobuhiro Haga, Susumu Kamata, Takeshi Shiota, Saichi Matsumoto, Toshihiko Okada, Hirokuni Jyoyama, 3-benzylidene-1-carbamoyl-2-pyrrolidone compounds useful as antiinflammatory agents ,(1992)

Timothy Bruno Lowinger, Uday Khire, Jeffrey Johnson, Jill E. Wood, Aniko Redman, William J. Scott, Roger A. Smith, Bernd Riedl, Jacques Dumas, Robert Sibley, Holia Hatoum-Mokdad, Inhibition of raf kinase using aryl and heteroaryl substituted heterocyclic ureas ,(1998)

Alan R Katritzky, Charles W Rees, Eric FV Scriven, None, Comprehensive heterocyclic chemistry II Pergamon. ,(1996)

Gunnar J Hanson, Inhibitors of p38 kinase Expert Opinion on Therapeutic Patents. ,vol. 7, pp. 729- 733 ,(1997) , 10.1517/13543776.7.7.729

David Gunn, Aniko Redman, Deborah Rauner, William Scott, Gerald Ranges, Michael Bombara, Joel Renick, Holger Paulsen, Roger Smith, Jinshan Chen, Inhibition of p38 kinase activity by aryl ureas. ,(1998)

Michael A. Stealey, Richard M. Weier, Richard A. Partis, Lifeng Geng, Gunnar J. Hanson, Michael Clare, Ashok Anantanarayan, 3 (5) -heteroaryl substituted pyrazoles as p38 kinase inhibitors ,(1998)